Advanced Infusion Systems Market

Advanced Infusion Systems Market Size (2022 to 2027)

The size of the global advanced infusion systems market to experience a healthy CAGR of 6.2% from 2022 to 2027. 

MARKET DRIVERS:

Increasing adoption of advanced infusion systems owing to the benefits associated with these systems, such as a rise in therapeutics effectiveness, safety, eliminating risks related to users, enhanced bioavailability, is the primary factor accelerating the global advanced infusion systems market growth.

Increasing healthcare spending is contributing to the growth of the advanced infusion system market. The rise in the incidence of diabetes, cancer, and related gastrointestinal diseases is also catalyzing the development of the market. Growing economies of emerging nations and awareness regarding the infusion systems among people are expected to favor the global advanced infusion systems market. The emergence of novel and innovative advanced infusion systems into the market creates lucrative growth opportunities for key market players in the advanced infusion systems market during the forecast period.

The expansion of healthcare in various countries is leading to the increasing adoption of advanced infusion systems. It is likely to continue due to the rising prevalence of chronic diseases, which offers several growth opportunities for stakeholders in the region. Increased focus of governments in different nations for research and development activities boosts growth opportunities for the key players functioning in the advanced infusion systems market during the forecast period.

MARKET RESTRAINTS:

Risks associated with the systems due to improper training for operating are one of the significant restraints to the global advanced infusion systems market growth. Stringent laws and regulatory bodies are challenging the development of the advanced infusion systems market.

Impact of COVID-19 on the global advanced infusion systems market:

The COVID-19 outbreak has had a huge effect on people's lives all over the world. A medical device and associated disposables are known as an advanced infusion system, are used to deliver drugs or fluids in solution to a patient. The medicine may be infused into the patient's body in various forms, including intravenous, arterial, subcutaneous, and epidural infusions, depending on the situation. There are different types of Advanced Infusion systems such as Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors. The prevalence of lifestyle-related diseases such as diabetes, increased surgical rates, aesthetic use in pain management, pediatric neonate food availability, and the rise in cancer patients contribute to the market's rapid growth.

Because of the COVID-19 outbreak, the market for infusion pumps has skyrocketed. Hospitals are running out of infusion pumps to treat COVID-19 patients who need nebulization support due to a rise in the number of infections worldwide. As a result, governments are placing large orders with suppliers for thousands of infusion pumps. Due to the sudden increase in demand for infusion pumps, both global and domestic players grow their production capacities to meet the demand, thus increasing growth prospects. As a result, Advanced Infusion Systems Market has positive growth due to the COVID-19 pandemic.

REPORT COVERAGE:

This research report on the global advanced infusion systems market has been segmented and sub-segmented based on product, application, end-users, and region.

Advanced Infusion Systems Market - By Application Type:

• Clinical Nutrition
• Chemotherapy
• Pain Management
• Diabetes
• Asthma Treatment

Based on the application type, the diabetes market segment is expected to dominate the global advanced infusion systems market and is likely to grow rapidly during the forecast period due to the high prevalence of diabetic patients worldwide and increasing demand for insulin pumps in-home care settings.

The chemotherapy market segment contributes a significant share of revenues to the advanced infusion systems market due to the increasing prevalence of cancer and the rising adoption rate of infusion systems in emerging countries.

Advanced Infusion Systems Market - By Product Type:

• Disposable Infusion System
• Elastomeric Infusion System
• Ambulatory Infusion System
• Volumetric Infusion System
• Patient Controlled Analgesia Pump
• Syringe Infusion System
• Implantable Infusion System

Advanced Infusion Systems Market - By End-Users:

• Diagnostic Centers
• Hospitals and Ambulatory Surgical Centers

Based on end-users, the Hospitals and Ambulatory Surgical Centers segment contributes the largest share to the advanced infusion systems market and is likely to grow significantly over the forecast period due to the factors such as the availability of technologically enhanced infusion systems in hospitals and the availability of trained professionals.

Advanced Infusion Systems Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, North America commands the most significant segment of the global advanced infusion systems market. In 2019, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It is mainly because of the high adoption of ambulatory pumps in managing chronic diseases, the high prevalence of rising penetration of advanced infusion systems, chronic diseases, and well-established healthcare infrastructure in the region. Asia-Pacific countries, particularly China and India) are expected to offer substantial growth opportunities for market players in the forecast period. Owing to the vast patient population, increasing incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and increasing disposable income.

KEY MARKET PLAYERS:

Companies leading the global advanced infusion systems market profiled in the report are Hospira, AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.

RECENT MARKET DEVELOPMENTS:

• In March 2020, Q Core Medical Company opened a new manufacturing unit in Europe to capitalize on the opportunities offered by the advanced infusion systems market due to the increasing geriatric population, increasing demand for adoption of infusion systems in healthcare, therapeutic effectiveness, and reliability.
• In March 2020, Bright Springs completed the acquisition of the specialty infusion business of advanced healthcare. This deal's principal objective is to expand their healthcare services to the patient base of the bright springs and benefits to stakeholders.
• In September 2019, the Eitan group entered into a strategic partnership with Canadian hospital specialties ltd. for expanding its business operation in Canada. This collaboration's principal objective is to provide distribution of infusion systems across Canada, which boosts the advanced infusion systems market in North America.